 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 10 concerning 454 Life Sciences
|
-
Transplantation Safety: New Virus Detected Using Genome Sequencer Technology
(02/11/2008)
454 Life Sciences, a part of Roche Applied Science, announced that researchers at Columbia University and Victorian Infectious Disease Reference Laboratory have discovered a new virus that was responsible for the deaths of three transplant ...
-
Researchers use the Genome Sequencer System to sequence and assemble the Pinot Noir Genome
(01/03/2008)
454 Life Sciences, a part of Roche Applied Science, announced that researchers from the Istituto Agrario San Michele all'Adige and Myriad Genetics have used the company's first generation instrument, the Genome Sequencer 20 System, to sequence and ...
-
Researchers Identify Virus Possibly Responsible for Declining Honeybee Population
(09/10/2007)
454 Life Sciences, a Roche company, announced that researchers at Columbia University, in collaboration with 454, have identified a virus implicated in the deaths of 2.4 million honeybee colonies - tens of billions of bees - using the company's ...
-
454 Life Sciences and Baylor College of Medicine Complete Sequencing of DNA Project
(06/04/2007)
The Genome of James Watson is the First to be Sequenced for Less than $1 Million
454 Life Sciences Corporation, in collaboration with scientists at the Human Genome Sequencing Center, Baylor College of Medicine, announced the completion of a project to sequence the genome of James D. Watson, Ph.D., co-discoverer of the ...
-
Roche acquires 454 Life Sciences to strengthen presence in ultra-fast gene sequencing
(04/02/2007)
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the ...
-
454 Life Sciences Initiates Collaborative Research Agreement with the Broad Institute
(12/21/2005)
Collaboration Aims to Facilitate Disease-Related Genomic Studies
454 Life Sciences Corporation announced the initiation of a collaborative research agreement with the Broad Institute of MIT and Harvard, a research collaboration of the Massachusetts Institute of Technology, Harvard University and its hospitals and ...
-
454 Life Sciences and the Genome Sequencing Center at Washington University in St. Louis Announce Collaborative Research Plan
(12/09/2005)
454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation , and the Genome Sequencing Center (GSC) at Washington University School of Medicine in St. Louis announced a collaborative research plan to sequence disease-causing ...
-
454 Life Sciences Publishes Breakthrough Genome Sequencing Technique
(08/02/2005)
Microfabrication Allows Sequencing in Record Time
454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation , announced the publication of a new genome sequencing technique 100 times faster than previous technologies. This is the first new technology for genome sequencing to ...
-
Roche and 454 Life Sciences enter exclusive world-wide agreement
(05/12/2005)
Roche Diagnostics adds ultra-fast nanotechnology-based genome sequencing system to its product portfolio and enters new market sector with significant potentialRoche and 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation announced ...
-
454 Life Sciences announces publication describing proprietary technology for massively parallel DNA amplification
(11/25/2003)
Enabling technology for miniaturized DNA amplification is described in the journal Electrophoresis
454 Life Sciences, an innovative technology company working to make the sequencing of whole genomes of any size commonplace and a majority-owned subsidiary of CuraGen Corporation announced that the Company's novel method to prepare and amplify all ...
|
|
|
Top